What Researchers Did
Researchers documented the 10-year recovery of a 59-year-old man who developed delayed neuropsychiatric sequelae after carbon monoxide poisoning and was treated with hyperbaric oxygen therapy.
What They Found
Delayed neuropsychiatric sequelae (DNS) affects 10%-30% of acute carbon monoxide poisoning patients. In this case, a 59-year-old man with DNS received hyperbaric oxygen therapy and returned to work for 10 years, showing improved frontal lobe blood flow and cognitive function. Although brain volume atrophy was observed over the decade, frontal lobe blood flow remained stable.
What This Means for Canadian Patients
For Canadian patients experiencing delayed neuropsychiatric sequelae after carbon monoxide poisoning, this case suggests that hyperbaric oxygen therapy may help improve cognitive function and cerebral blood flow. It offers a potential path to long-term recovery and a return to daily activities, even years after the initial poisoning event. Patients should discuss treatment options with their healthcare providers.
Canadian Relevance
This study covers carbon monoxide poisoning, which is a Health Canada-recognized indication for hyperbaric oxygen therapy. No direct Canadian connection or authors were identified.
Study Limitations
As a single case report, the findings cannot be generalized to all patients with delayed neuropsychiatric sequelae from carbon monoxide poisoning.